XORTX Therapeutics (XRTX) Interest Coverage Ratio (2020 - 2023)

XORTX Therapeutics (XRTX) posted Interest Coverage Ratio of 981.7 for Q1 2023, down 3347.4% on a QoQ basis from 28.48 in Q4 2022, and up 9.49% year-over-year from 896.58 in Q1 2022.

XORTX Therapeutics (XRTX) Interest Coverage Ratio (2020 - 2023) Analysis & Trends

XORTX Therapeutics' Interest Coverage Ratio history runs 4 years deep, the most recent figure standing at 981.7 for Q1 2023.

  • Quarterly Interest Coverage Ratio rose 9.49% year-over-year to 981.7 in Q1 2023, while the trailing twelve-month figure through Mar 2026 was 1.052142055511294e+18 (up 140.12% YoY) and the FY2025 annual result came in at 62.44, down 138.52% from the prior year.
  • Interest Coverage Ratio was 981.7 for Q1 2023 at XORTX Therapeutics, down from 28.48 in the prior quarter.
  • Across five years, Interest Coverage Ratio topped out at 1302.42 in Q2 2021 and bottomed at 1084.69 in Q1 2022.
  • A 4-year average of 55.88 and a median of 24.87 in 2022 frame the typical range for Interest Coverage Ratio.
  • Peak annual rise in Interest Coverage Ratio reached 87.71% in 2022, while the deepest fall reached 364.31% in 2022.
  • XORTX Therapeutics' Interest Coverage Ratio stood at 584.84 in 2020, then plunged by 139.63% to 231.77 in 2021, then surged by 87.71% to 28.48 in 2022, then plunged by 3347.4% to 981.7 in 2023.
  • Business Quant data shows XRTX's Interest Coverage Ratio at 981.7 in Q1 2023, 28.48 in Q4 2022, and 24.87 in Q3 2022.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Interest Cover (Qtr)
1 Oculis Holding AG 66,801.52 Bn 66,801.23 Bn - 658.42
2 Nanobiotix 1,916.61 Bn 1,916.55 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - -157.58
4 BeOne Medicines 471.65 Bn 466.85 Bn 1.35 Bn 7.60
5 Vertex Pharmaceuticals 121.94 Bn 114.69 Bn 2.59 Bn 2.71
6 Regeneron Pharmaceuticals 69.85 Bn 61.09 Bn 3.31 Bn 22.72
7 Belite Bio 63.06 Bn 63.06 Bn - -
8 Argenx Se 55.74 Bn 50.56 Bn 1.41 Bn -
9 Revolution Medicines 37.48 Bn 37.48 Bn - -0.38
10 XORTX Therapeutics 2.91 Bn 2.91 Bn - -

Historic Data

Download Data
DateValue
Mar 31, 2023 -981.70
Dec 31, 2022 -28.48
Sep 30, 2022 -24.87
Jun 30, 2022 -81.50
Mar 31, 2022 -1,084.69
Dec 31, 2021 -231.77
Sep 30, 2021 293.96
Jun 30, 2021 1,302.42
Mar 31, 2021 410.38
Dec 31, 2020 584.84
Sep 30, 2020 456.11